Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Fujisawa Licenses Tacrolimus-coated Stents to Italy
September 30, 2002
- Sysmex: BACTANA to Detect Bacteria in Food
September 30, 2002
- Korosho to Develop Drug Safety Prediction System
September 30, 2002
- BD Japan: BD BBL CultureSwab EZII
September 30, 2002
- Drafting of GL for Physician-led Clinical Trials Progresses
September 30, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
September 30, 2002
- Ivermectin, Micafungin Recommended for Approval
September 30, 2002
- FDA's Registration Criteria for Drugs to Treat Obesity Outlined: JHSF Seminar
September 30, 2002
- Korosho to Shortly Propose Policy for Health Insurance Reform: Senior Official
September 30, 2002
- b-blockers Not Always More Effective than Ca Antagonists
September 30, 2002
- BUSINESS NEWS IN BRIEF
September 30, 2002
- COLIN Medical Instruments Receives FDA Approval for Prodigy
September 30, 2002
- NEW PRODUCTS
September 30, 2002
- Terumo Prepares CD-ROM on Proper Use of Drip Infusion Pumps
September 30, 2002
- Kyorin Revises Business Forecasts Downward
September 30, 2002
- GEYMS: New Multislice CT, LightSpeed Ultra16
September 30, 2002
- Medical Vita Japan Recruits Trial Subjects for Medical Institutions
September 30, 2002
- New Nursing Care Fees to Be Set in January
September 30, 2002
- Daiichi to Restructure Global R&D System
September 23, 2002
- PRESS SEMINAR
September 23, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…